( ass and best-in-classpharmaceutical pr...)New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia,Health

ass and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

    C-LLY


    (i)    APA Practice Guidelines. Am J Psychiatry. 2004.

    (ii)   Maguire GA. Am J Health Syst Pharm. 2002;59(17 suppl 5):S4-S11.

    (iii)  Modestin J, Ammann R. Schizophr Bull. 1996;22(1):69-82.

    (iv)   Olfson M, et al. Psychiatr Serv. 1999;50(5):667-673.

(v) Lieberman JA, et al. J Clin Psychopharmacol. 1998;18(2 suppl 1):20S-24S.

(vi) APA. DSM-IV-TR; 2000.

(vii) Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action. A hypothesis tested and rejected. Arch Gen Psychiatry 2003;60:1228-1235; Leucht S, Busch R, Hamann J, et al. Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confired and extended. Biol Psychiatry 2005;57:1543-1549; Correll CU, Malhotra AK, Kaushik S, et al. Early prediction of antipsychotic response in schizophrenia. J Clin Psychopharmacol 2003;26:554-559.

(viii) Weiden P, Scheifler P, Diamond R, et al. Breakthroughs in Antipsychotic Medications. New York: W.W. Norton & Company, 1999.

(ix) "Schizophrenia: What You Need to Know" Mental Health America http://www.mentalhealthamerica.net/go/information/get- info/schizophrenia/schizophrenia-what-you-need-to-know/schizophrenia-what-you- need-to-know. Accessed March 14, 2007

(x) PRODIGY Knowledge Guidance: Schizophrenia. http://cks.library.
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
4. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
5. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
6. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
7. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
8. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
9. Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
10. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
11. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability